global-longlife-hospital-and-researchGlobal Longlife Hospital and Research Ltd.

₹22.9+0.00%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Deep Value Pick

Global Longlife Hospital and Research Ltd. is currently underperforming against its peers in terms of growth, profitability, and valuation metrics. However, due to its low debt levels, it could be considered a deep value pick for investors looking for potential upside as the company stabilizes. Peers like Max Healthcare and Apollo Hospitals are strong performers due to robust growth and profitability metrics, making them leaders in the sector.

Key Points

• Global Longlife Hospital shows 0% revenue growth and EPS, indicating stagnation.
• Max Healthcare leads in revenue growth YoY at 18.49% and EPS at 11.0671.
• Apollo Hospitals has a strong ROE of 20.513% and a favorable PE of 85.15, indicating good profitability relative to its price.
• Aster DM Healthcare is a deep value pick with a PE of 5.05 and a reasonable debt ratio, despite its declining revenues.
• Fortis Healthcare has the highest PE at 1094.63, indicating it is overvalued given its low profitability metrics.

Top Performers

Max Healthcare Institute Ltd.

Highest revenue growth YoY (18.49%) and strong EPS growth (11.0671), with solid profitability metrics.

Apollo Hospitals Enterprise Ltd.

Strong ROE (20.513%) and a favorable PE ratio (85.15), indicating good value for growth.

Narayana Hrudayalaya Ltd.

High ROE (24.2658%) and solid growth metrics with manageable debt levels.

Explore

Watchlists

Command Palette